Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
|Articles|September 9, 2006
Roundtable Discussion on Microsulis Microwave
Author(s)James Daniell, MD
OBGYN.net Conference CoverageFrom ISGE - Montreal, Canada - April, 1999
Advertisement
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of RealPlayer, available
Advertisement
Related to this article
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Jessica Shepherd, MD, MBA, FACOG, joins Missed & Dismissed to discuss why perimenopause is overlooked and how disparities shape who gets care.
Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Missed & Dismissed: From perimenopause to menopause, the transition medicine keeps missing
2
Multi-society framework ties cardiovascular risk to female life stages
3
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
4
Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause
5